The effect of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on epidermal growth factor (EGF) receptor activity of the rat hepatic plasma membrane was studied. TCDD causes a significant reduction in EGF binding at an early stage of toxicity (day 2) and at very low doses (1 pug/kg, single i.p., rat). This reduction appears to be due to a decline in the number of receptors. There is a good correlation between levels of decline in EGF binding and loss of body weight among TCDD-treated rats. The reduction in EGF binding occurs at a relatively low dose in the guinea pig (a very sensitive species) and at high doses in the hamster (a tolerant species). Among three mice strains, TCDD (115 ptg/kg, single i.p.) caused 98% reduction in EGF binding in the sensitive strains (C57BL/6J and CBA/J) but only a 50% reduction in the tolerant strain (AKR/J). To relate the above biochemical changes to in vivo effects, TCDD was postnatally administered (through mother's milk) to mouse neonates. The most prominent toxic manifestations were early eye opening and incisor eruption, loss in body weight gain, and retardation of hair growth. All of these symptoms have been ascribed to EGF effects. TCDD was also found to stimulate phosphorylation of the EGF receptor in the rat hepatic plasma membrane. This phosphorylation effect was observed at day 1 and persisted until the end of the test (day 10). It has long been recognized that agents causing reduction in number of EGF receptors (e.g., phorbol esters) elicit in vivo cellular responses that are similar to those caused by exposure to excess doses of growth factors. Accordingly, a hypothesis has been proposed to ascribe some of the EGF-like effects of TCDD, such as fatty infiltration of the liver and hyperplastic proliferation of gastric epithelia and epidermal cells to its action on the EGF receptor. 2, 3, 7, is an extremely toxic compound. The oral LD50 values in the male guinea pig and the rat are cited as 0.6 ,g/kg and 22 pug/kg, respectively (1). The action pattern of TCDD is unusual in that animals treated with a single dose steadily lose weight for several weeks, until death occurs, usually in 2-8 weeks. There are marked species differences in sensitivity (2): e.g., as compared to the above species, the Golden Syrian hamster is very tolerant to TCDD; its LD50 value is cited as >5000 pug/kg. Furthermore, the toxic manifestations also qualitatively vary from species to species. The basic biochemical cause for such toxic actions of TCDD is unknown (3).
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an extremely toxic compound. The oral LD50 values in the male guinea pig and the rat are cited as 0.6 ,g/kg and 22 pug/kg, respectively (1) . The action pattern of TCDD is unusual in that animals treated with a single dose steadily lose weight for several weeks, until death occurs, usually in 2-8 weeks. There are marked species differences in sensitivity (2) : e.g., as compared to the above species, the Golden Syrian hamster is very tolerant to TCDD; its LD50 value is cited as >5000 pug/kg. Furthermore, the toxic manifestations also qualitatively vary from species to species. The basic biochemical cause for such toxic actions of TCDD is unknown (3) .
We have recently found that many plasma membrane proteins and functions of the hepatocytes from TCDD-treated rats are quantitatively different from those of untreated rats (4) (5) (6) .
As a follow-up of such a study, the current investigation was undertaken with the following objectives: (i) find several biochemical parameters on the plasma membrane that are severely affected by TCDD, (ii) study whether any of the changes occur at low enough doses and at very early stages in susceptible species, and only at high doses in tolerant species, and (iii) make an attempt to relate such effects to some of the toxic manifestations in vivo.
MATERIALS AND METHODS
Animals and Chemicals. Male Sprague-Dawley rats (150-200 g) and Golden Syrian hamsters (80-90 g) were obtained from Spartan Laboratory Animals (Haslett, MI). Male guinea pigs (200-250 g) were obtained from Michigan Department of Health, Lansing, MI and female BALB/c mice were purchased from Harlan Laboratories (Haslett, MI). Inbred mouse strains C57BL/6J, CBA/J, and AKR/J were obtained from The Jackson Laboratory. Food and water were provided ad lib. All chemicals used in vivo were administered to the animals intraperitoneally (i.p.) as solutions in either corn oil/acetone (9:1; TCDD), 0.85% NaCl (phenobarbital), or corn oil (all others). Control animals received an equivalent volume of the vehicle only.
TCDD was a gift from Dow and was >99% pure (GLC examined); 3,4,3',4'-tetrachloroazoxybenzene was generously given to us by M. T. Stephen Hsia (University of Wisconsin, Madison, WI) and was >99% pure; sodium phenobarbital was purchased from Mallinckrodt; 3-methylcholanthrene, and epidermal growth factor (EGF) were from Sigma; Aroclor-1242, a polychlorinated biphenyl mixture containing 42% chlorine, was a gift from Monsanto; 3,4,3',4'-tetrachlorobiphenyl (>99% pure) was obtained from Analabs, North Haven, CT; and 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane >99% pure was a gift from Mon mouli et al. (10) with minor modifications as described (4, 5) . Phosphorylation assay was done essentially as described by Rubin et al. (11) . Other details are given in Fig. 5 legend (12, 13) .
Growth Characteristics of Neonatal BALB/c Mice Exposed to TCDD Through Mother's Milk. Females of BALB/c mice (15-18 days pregnant) were housed in plastic cages individually, and food and water were provided ad lib. The time of delivery was closely followed and within 3 hr, the dams were treated i.p. with a single dose of either TCDD in corn oil/acetone (9:1) at 10 pg/kg or with the vehicle alone (0.5 ml per 100 g of body weight). Prior to treatment, two littermates from each litter were exchanged and marked to identify them from the original littermates. Body weights of the neonates were recorded daily and were checked for incisor eruption and eyelid opening twice daily (between 8 and 9 a.m. and between 5 and 6 p.m.). The day of delivery was considered as day 0. Hair diameter and length were measured on day 14 from samples taken from the mid-right dorsal region. They were mounted on glass slides with glycerol and measured under a microscope. EGF in 0.85% NaCl was injected subcutaneously to newborn mice daily at 2 ttg/g of body weight.
Body weights and other developmental parameters were measured as described above. All animals were sacrificed at 22 days of age and thymus weights were recorded.
RESULTS
Time Course of Biochemical Changes. First, we have examined the effects of in vivo-administered TCDD on three receptors of the rat hepatic plasma membrane at various doses to assess which of these is most sensitive (Fig. 1) . It is clear from the results that the effect of TCDD on EGF binding was most pronounced, followed by that of Con A and insulin. It is significant that the effect on EGF binding is observable at a dose as low as 0.1 pug/kg. It was also noted that insulin binding was significantly lower at the highest dose (115 pg/kg) and higher at low doses as compared to the corresponding control preparation at 10 days after treatment.
In view of the sensitivity of EGF binding to TCDD treatment, we examined the time course of TCDD effect after a single i.p. dose (25 pg/kg; Fig. 2 ). During the 40-day observation period, TCDD-treated rats gained consistently less body weight than did control rats. During the same period, the level of EGF binding was continuously suppressed. The decline was noticeable on the second day, reached a maximum on day 20, and by day 40 a trend of apparent recovery was observed. At this dose and treatment, this apparent recovery is believed to result from mortality of the susceptible population. The average mortality was 0 at day 20, but reached 20%-30% by day 40; therefore, the data at this time point represent the value from surviving animals.
To study whether the reduction in EGF binding in vitro is generally related to in vivo TCDD effects, the body weight changes of individual TCDD-treated rats at two different doses (25 and 115 jig/kg) were compared with the levels of '25I-labeled EGF binding to the hepatic hepatic plasma membrane isolated from each rat on day 20 after treatment. Body weight levels (expressed as % initial body weight) of individual rats were plotted against specific EGF binding. The curve was generated by computer, using the points of all preparations (i.e., 25 ,.g/kg, 115 ug/kg). Data were analyzed using least-squares regression statistics. The coefficient of correlation (r) was 0.9051 among treated rats (data not shown). No correlation between body weight levels and 125I1 labeled EGF binding was seen in control rats.
The nature of the changes in the EGF receptor was studied by Scatchard analysis of ligand-receptor binding (Fig. 3) . The results indicate that EGF binding generally shows a biphasic relationship, as shown by Ivanovic and Weinstein (14, 15) , and that the number of high as well as low affinity receptors in the TCDD-treated rats was reduced without any apparent changes in the receptor affinity.
To study whether such biochemical changes are also evoked by other toxic chemicals or only by TCDD, we assessed the effect of various xenobiotics in vivo on EGF binding in vitro (Table 1) . Among the nine chemicals tested, only TCDD and Aroclor-1242 caused a significant decrease in EGF binding. In both cases, the effects appear to be dose related. It must be noted that rather high doses were psed for other chemicals, resulting in the manifestation of toxicities in most cases. Yet, even under these conditions no reduction in EGF binding was observed.
Interspecific Comparison of Biochemical Changes. To further understand the relationship between these biochemical changes and susceptibility of these species to TCDD (see ref.
2 for discussion), the dose response of EGF binding was ex- amined. Ten days after single i.p. treatments, plasma membranes were isolated from each animal, and the levels of EGF binding were quantified. The results (Fig. 4) indicate that the guinea pig system was most sensitive, followed by that of the rat and the hamster. If one adopts the 150 (i.e., the dose of TCDD to suppress EGF binding to 50% of the control level) as a critical dose, the rat and the hamster may be considered to be -14 and -32 times less sensitive, respectively, than the guinea pig in this regard. At I75, the species difference was much greater. Next, inbred strains of mice (C57BL/6J, CBA/J, and AKR/J) known to show different degrees of tolerance to TCDD were examined (16). The results ( (17, 18) . The action of TCDD in this regard was clear (Table 3) in that both events occur at an earlier age in the treated ones than in the control. Other parameters examined also show that the lesions caused by TCDD are remarkably similar to those occurring in EGF-treated animals (see ref. 19) .
When the hepatic plasma membrane was isolated from the treated and control rats, incubated with [y-32P]ATP, subject- ed to gel electrophoresis, and autoradiographed, it became evident that the band intensity, representing 32p incorporation into the EGF receptor, increased in plasma membrane from animals sacrificed at days 1, 2, and 10 ( Fig. 5) . The results agree with the observation made by others (19, 20) that agents affecting EGF receptors cause an increase in phosphorylation of the EGF receptor. Also, it was noted that there are other bands of which intensities were much higher (23) and thyroxine (24) , and a solvent dimethylsulfoxide (25) . At least the first three groups of agents are known to cause or promote neoplastic development in various tissues. The most intriguing aspect of this phenomenon is that the tissues and the cells exhibiting loss of EGF receptor activities by these treatments elicit responses characteristic of excess EGF (15, 19, 20) . For (15, 20) . Also, Rose et al. (26) have found that EGF promotes skin tumors in mice treated with methylcholanthrene, as in the case of 12-tetradecanoylphorbol 13-acetate. The tumor-promoting potential of TCDD in mouse skin has also been shown by Poland et al. (27) in hairless mice.
The cause of this EGF-like effect by agents that decrease EGF receptor activity as proposed by DeLarco and Tadaro (28) and Weinstein and his associates (15, 20, 29) appears to be due to the production of endogenous growth factor(s) by the affected cells and tissues. In the case of transforming viruses, such growth factors (termed TGF for "transformation growth factors") have actually been found, isolated, and characterized (30, 31 ). An alternative explanation for these events may be that these agents or treatment ultimately cause phosphorylation of the EGF receptor, as shown in the case of 12-tetradecanoylphorbol 13-acetate (19) , dimethylsulfoxide (25), Rous sarcoma virus (22) , partial hepatectomy (11, 32) , etc., and that this phosphorylation action alone could activate a chain of events that is normally triggered by the binding of the ligand, EGF, to its receptor. In turn, these cells with phosphorylated receptors may no longer require external ligands to process the messages of transaction.
In the current study, we have found that TCDD does indeed increase phosphorylation of the EGF receptor in the rat liver plasma membrane, and that it has the same in vivo effects as exogenous EGF with regard to the early eyelid opening and tooth eruption in neonatal mice. The eyelid effect has been cited as the most specific biological index of EGF activity in vivo (19) .
With this evidence, we propose the hypothesis that some of the toxic manifestations of TCDD, particularly the hyperplastic response among epithelial tissues, is a result of the action of TCDD on the EGF receptor. Table 3 . Effect of TCDD on eyelid opening, incisor eruption, and hair growth on neonatal BALB/c mice
Eyelid opening, days 13.7 ± 0.5 (14) 11.4 ± 0.5 (13) 10.7 ± 0.5 (10) Tooth eruption, days Lower 9.9 ± 0.5 (14) 9.0 ± 0.4 (13) 7.5 ± 0. If one examines the toxic manifestations caused by TCDD from such a viewpoint, one cannot help but notice many similarities between them and those caused by EGF administration in vivo and in vitro. They are, for example, fatty invasion of the liver (17, 33) , inhibition of terminal differentiation of keratinocytes (34, 35) , skin cancer promotion (26, 27) , proliferation of conjunctiva cells (18, 36) , inhibition of gastric secretion (30, 36, 37) , ornithine decarboxylase changes (38, 39) , and serum hypertriglyceridemia (17, 40) , in addition to hair growth, early eye opening, etc., as shown in the current work. While in several cases the experimental conditions for TCDD studies differ from those of EGF and caution is needed to draw a direct analogy, these similarities are remarkable and therefore the relationship between TCDD and EGF effects warrants further attention.
